SEC Comment Letter 0000000000-24-000555 to BIOREGENX, INC. (BRGX) (CIK 0001593184) (BRGX)
BIOREGENX, INC. (BRGX) (CIK 0001593184)
Date: Jan. 17, 2024 · CIK: 0001593184 · Accession: 0000000000-24-000555
AI Filing Summary & Sentiment
File numbers found in text: 000-56345
Letter
United States securities and exchange commission logo January 16, 2024 Thomas Powers Chief Executive Officer Findit, Inc. 5051 Peachtree Corners Circle, #200 Peachtree Corners, GA 30092 Re:Findit, Inc. Preliminary Information Statement on Schedule 14C Filed February 7, 2023 File No. 000-56345 Dear Thomas Powers: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Technology cc: Thomas C. Cook, Esq.
Show Raw Text
United States securities and exchange commission logo
January 16, 2024
Thomas Powers
Chief Executive Officer
Findit, Inc.
5051 Peachtree Corners Circle, #200
Peachtree Corners, GA 30092
Re:Findit, Inc.
Preliminary Information Statement on Schedule 14C
Filed February 7, 2023
File No. 000-56345
Dear Thomas Powers:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Technology
cc: Thomas C. Cook, Esq.